title: Geographic accessibility to clinical trials for advanced cancer in the United States.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Galsky
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
authors.forename: Kristian D
authors.initials: KD
authors.lastname: Stensland
authors.affiliation: Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Russell B
authors.initials: RB
authors.lastname: McBride
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
authors.forename: Asma
authors.initials: A
authors.lastname: Latif
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
authors.forename: Erin
authors.initials: E
authors.lastname: Moshier
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
authors.forename: William K
authors.initials: WK
authors.lastname: Oh
authors.affiliation: Divisions of General Internal Medicine and Pulmonary and Critical Care, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Juan
authors.initials: J
authors.lastname: Wisnivesky
mesh_terms: D002986:Clinical Trials as Topic; D006297:Health Services Accessibility; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D014481:United States